Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17676 - 17700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Colforsin	Investigational	TOB1	10140	upregulated	Colforsin results in increased expression of TOB1 mRNA	17q21.33	A21715
Colforsin	Investigational	TRGV9	6983	upregulated	Colforsin results in increased expression of TRGV9 mRNA	7p14.1	A21714
Colforsin	Investigational	TYR	7299	upregulated	Colforsin results in increased expression of TYR mRNA	11q14.3	A21748
Colforsin	Investigational	TYRP1	7306	upregulated	Colforsin results in increased expression of TYRP1 mRNA	9p23	A21739 A21748
Colforsin	Investigational	UBE2J1	51465	upregulated	Colforsin results in increased expression of UBE2J1 mRNA	6q15	A21714
Colforsin	Investigational	WT1	7490	upregulated	Colforsin results in increased expression of WT1 mRNA	11p13	A21740
Colforsin	Investigational	ZBTB10	65986	downregulated	Colforsin results in decreased expression of ZBTB10 mRNA	8q21.13	A21714
Colforsin	Investigational	ZFP36L2	678	downregulated	Colforsin results in decreased expression of ZFP36L2 mRNA	2p21	A21716
Copper	Approved Investigational	AADAT	51166	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of AADAT mRNA	4q33	A21749
Copper	Approved Investigational	AARS	16	upregulated	[Disulfiram binds to Copper] which results in increased expression of AARS mRNA	16q22.1	A21750
Copper	Approved Investigational	ABCA1	19	upregulated	[Disulfiram binds to Copper] which results in increased expression of ABCA1 mRNA	9q31.1	A21750
Copper	Approved Investigational	ABCA13	154664	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ABCA13 mRNA	7p12.3	A21749
Copper	Approved Investigational	ABCA3	21	upregulated	[Disulfiram binds to Copper] which results in increased expression of ABCA3 mRNA	16p13.3	A21750
Copper	Approved Investigational	ABCA5	23461	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ABCA5 mRNA	17q24.3	A21749
Copper	Approved Investigational	ABCB10	23456	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ABCB10 mRNA	1q42.13	A21749
Copper	Approved Investigational	ABCC2	1244	upregulated	[Organoselenium Compounds binds to Copper] which results in increased expression of ABCC2 mRNA	10q24.2	A21751
Copper	Approved Investigational	ABCC3	8714	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ABCC3 mRNA	17q21.33	A21749
Copper	Approved Investigational	ABCF2	10061	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ABCF2 mRNA	7q36.1	A21749
Copper	Approved Investigational	ABCG1	9619	upregulated	[Disulfiram binds to Copper] which results in increased expression of ABCG1 mRNA	21q22.3	A21750
Copper	Approved Investigational	ABHD11	83451	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ABHD11 mRNA	7q11.23	A21749
Copper	Approved Investigational	ABHD17C	58489	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ABHD17C mRNA	15q25.1	A21749
Copper	Approved Investigational	ABHD4	63874	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ABHD4 mRNA	14q11.2	A21749
Copper	Approved Investigational	ABL2	27	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA	1q25.2	A21749
Copper	Approved Investigational	ACAD11	84129	upregulated	[Disulfiram binds to Copper] which results in increased expression of ACAD11 mRNA	3q22.1	A21750
Copper	Approved Investigational	ACAD9	28976	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACAD9 mRNA	3q21.3	A21749

Displaying entries 17676 - 17700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability